Table 1 Patient demographics and baseline characteristics
From: Real-time evaluation of the independent analgesic efficacy of dexmedetomidine
Variation a | DEX group | MID group | t/X2 | P-value |
|---|---|---|---|---|
Age, years | 55.55 (14.98) | 55.77 (12.92) | 1.332 | 0.212 |
Height, cm | 165.56 (9.45) | 166.50 (7.86) | 1.107 | 0.654 |
Weight, kg | 69.82 (11.10) | 68.37 (11.81) | 1.509 | 0.073 |
BMI, kg/m2 | 25.41 (2.94) | 24.57 (3.31) | 1.400 | 0.139 |
Anaesthesia time, min | 132.78 (42.74) | 139.11 (50.47) | 1.661 | 0.086 |
Operation time, min | 82.28 (36.38) | 86.56 (44.69) | 1.971 | 0.093 |
Bleeding, ml | 39.73 (50.43) | 29.55 (34.45) | 2.321 | 0.079 |
Intraoperative infusion, ml | 534.66 (230.36) | 535.25 (221.81) | 1.225 | 0.393 |
Baseline SBP, mmHg | 143.92 (29.11) | 136.75 (30.30) | 1.438 | 0.364 |
Baseline DBP, mmHg | 83.50 (11.21) | 79.17 (11.02) | 1.035 | 0.950 |
Baseline MAP, mmHg | 99.94 (15.54) | 95.33 (13.18) | 1.390 | 0.412 |
Baseline HR, beats/min | 75.56 (14.89) | 73.58 (12.56) | 1.405 | 0.396 |
Variation b | ||||
 ASA score I–II (%) | 65 (73.86) | 74 (84.09) | 2.772 | 0.096 |
 ASA score III–IV (%) | 23 (26.14) | 14 (15.91) |  |  |
 Female sex (%) | 53 (60.23) | 45 (51.14) | 1.474 | 0.225 |
 Male sex (%) | 35 (39.77) | 43 (48.86) |  |  |